Terms: = Sarcomas AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Prognosis
6 results:
1. Different oncological features of colorectal cancer codon-specific
Ahn HM; Kim DW; Oh HJ; Kim HK; Lee HS; Lee TG; Shin HR; Yang IJ; Lee J; Suh JW; Oh HK; Kang SB
World J Gastroenterol; 2023 Aug; 29(32):4883-4899. PubMed ID: 37701134
[TBL] [Abstract] [Full Text] [Related]
2. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
Halalsheh H; Amer S; Sultan I
Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
[TBL] [Abstract] [Full Text] [Related]
3. Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells.
Hu C; Wang Y; Liu C; Shen R; Chen B; Sun K; Rao H; Ye L; Ye J; Tian S
Med Sci Monit; 2020 Jul; 26():e924126. PubMed ID: 32683393
[TBL] [Abstract] [Full Text] [Related]
4. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
[TBL] [Abstract] [Full Text] [Related]
5. [Evaluation of selected cytokines in children and adolescents with osteosarcoma at diagnosis - preliminary report].
Markiewicz K; Zeman K; Kozar A; GoĊebiowska-Wawrzyniak M
Med Wieku Rozwoj; 2011; 15(1):25-31. PubMed ID: 21786509
[TBL] [Abstract] [Full Text] [Related]
6. Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.
Yoo HJ; Yun BR; Kwon JH; Ahn HS; Seol MA; Lee MJ; Yu GR; Yu HC; Hong B; Choi K; Kim DG
Exp Mol Med; 2009 Feb; 41(2):102-15. PubMed ID: 19287191
[TBL] [Abstract] [Full Text] [Related]
